 | • レポートコード：MRC2-11QY11870 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：New Technology |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はエピジェネティックのグローバル市場について調査・分析したレポートです。種類別（試薬、キット、器具、酵素、サービス）市場規模、用途別（学術研究所、バイオテクノロジー企業、バイオ製薬企業、診断企業）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別エピジェネティックの競争状況、市場シェア ・世界のエピジェネティック市場：種類別市場規模 2015年-2020年（試薬、キット、器具、酵素、サービス） ・世界のエピジェネティック市場：種類別市場規模予測 2021年-2026年（試薬、キット、器具、酵素、サービス） ・世界のエピジェネティック市場：用途別市場規模 2015年-2020年（学術研究所、バイオテクノロジー企業、バイオ製薬企業、診断企業） ・世界のエピジェネティック市場：用途別市場規模予測 2021年-2026年（学術研究所、バイオテクノロジー企業、バイオ製薬企業、診断企業） ・北米のエピジェネティック市場分析：米国、カナダ ・ヨーロッパのエピジェネティック市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのエピジェネティック市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のエピジェネティック市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのエピジェネティック市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Illumina、Qiagen、Abcam、Merck & Co、Sigma-Aldrich、New England Biolabs、Thermo Fisher Scientific、Diagenode、Active Motif、Roche Diagnostics、Eisai、Novartis ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Epigenetics is the study of heritable phenotype changes that do not involve alterations in the DNA sequence.
The global market for epigenetic device market is expected to be driven by the advancement in technology. The key drivers of the market are the increasing cases prevalence of cancer, growing ageing population and increase in obese population.
Market Analysis and Insights: Global Epigenetic Market
The global Epigenetic market size is projected to reach US$ 6970.3 million by 2026, from US$ 6452.2 million in 2020, at a CAGR of 7.4%% during 2021-2026.
Global Epigenetic Scope and Market Size
Epigenetic market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Epigenetic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Illumina
Qiagen
Abcam
Merck & Co
Sigma-Aldrich
New England Biolabs
Thermo Fisher Scientific
Diagenode
Active Motif
Roche Diagnostics
Eisai
Novartis
Market segment by Type, the product can be split into
Reagents
Kits
Instruments
Enzymes
Services
Market segment by Application, split into
Academic Research Institutes
Biotechnology Companies
Biopharmaceutical Companies
Diagnostic Companies
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Epigenetic Revenue
1.4 Market by Type
1.4.1 Global Epigenetic Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Reagents
1.4.3 Kits
1.4.4 Instruments
1.4.5 Enzymes
1.4.6 Services
1.5 Market by Application
1.5.1 Global Epigenetic Market Share by Application: 2020 VS 2026
1.5.2 Academic Research Institutes
1.5.3 Biotechnology Companies
1.5.4 Biopharmaceutical Companies
1.5.5 Diagnostic Companies
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Epigenetic Market Perspective (2015-2026)
2.2 Global Epigenetic Growth Trends by Regions
2.2.1 Epigenetic Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Epigenetic Historic Market Share by Regions (2018-2019)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Competition Landscape by Key Players
3.1 Epigenetic Revenue by Players (2019-2020)
3.2 Epigenetic Key Players Head office and Area Served
3.3 Key Players Epigenetic Product/Solution/Service
3.4 Date of Enter into Epigenetic Market
3.5 Key Players Epigenetic Funding/Investment Analysis
3.6 Global Key Players Epigenetic Valuation & Market Capitalization
3.7 Mergers & Acquisitions, Expansion Plans
4 Global Epigenetic Market Size by Type (2019-2026)
5 Global Epigenetic Market Size by Application (2019-2026)
6 North America
6.1 North America Epigenetic Market Forecast (2019-2026)
6.2 Epigenetic Key Players in North America (2019-2020)
6.3 North America Epigenetic Market Size by Type (2015-2020)
6.4 North America Epigenetic Market Size by Application (2015-2020)
7 Europe
7.1 Europe Epigenetic Market Forecast (2019-2026)
7.2 Epigenetic Key Players in Europe (2019-2020)
7.3 Europe Epigenetic Market Size by Type (2015-2020)
7.4 Europe Epigenetic Market Size by Application (2015-2020)
8 China
8.1 China Epigenetic Market Forecast (2019-2026)
8.2 Epigenetic Key Players in China (2019-2020)
8.3 China Epigenetic Market Size by Type (2015-2020)
8.4 China Epigenetic Market Size by Application (2015-2020)
9 Japan
9.1 Japan Epigenetic Market Forecast (2019-2026)
9.2 Epigenetic Key Players in Japan (2019-2020)
9.3 Japan Epigenetic Market Size by Type (2015-2020)
9.4 Japan Epigenetic Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Epigenetic Market Forecast (2019-2026)
10.2 Epigenetic Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Epigenetic Market Size by Type (2015-2020)
10.4 Southeast Asia Epigenetic Market Size by Application (2015-2020)
11 India
11.1 India Epigenetic Market Forecast (2019-2026)
11.2 Epigenetic Key Players in India (2019-2020)
11.3 India Epigenetic Market Size by Type (2015-2020)
11.4 India Epigenetic Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Epigenetic Market Forecast (2019-2026)
12.2 Epigenetic Key Players in Central & South America (2019-2020)
12.3 Central & South America Epigenetic Market Size by Type (2015-2020)
12.4 Central & South America Epigenetic Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Illumina
13.1.1 Illumina Company Details
13.1.2 Illumina Business Overview
13.1.3 Illumina Epigenetic Introduction
13.1.4 Illumina Revenue in Epigenetic Business (2019-2020))
13.1.5 Illumina Recent Development
13.2 Qiagen
13.2.1 Qiagen Company Details
13.2.2 Qiagen Business Overview
13.2.3 Qiagen Epigenetic Introduction
13.2.4 Qiagen Revenue in Epigenetic Business (2019-2020))
13.2.5 Qiagen Recent Development
13.3 Abcam
13.3.1 Abcam Company Details
13.3.2 Abcam Business Overview
13.3.3 Abcam Epigenetic Introduction
13.3.4 Abcam Revenue in Epigenetic Business (2019-2020))
13.3.5 Abcam Recent Development
13.4 Merck & Co
13.4.1 Merck & Co Company Details
13.4.2 Merck & Co Business Overview
13.4.3 Merck & Co Epigenetic Introduction
13.4.4 Merck & Co Revenue in Epigenetic Business (2019-2020))
13.4.5 Merck & Co Recent Development
13.5 Sigma-Aldrich
13.5.1 Sigma-Aldrich Company Details
13.5.2 Sigma-Aldrich Business Overview
13.5.3 Sigma-Aldrich Epigenetic Introduction
13.5.4 Sigma-Aldrich Revenue in Epigenetic Business (2019-2020))
13.5.5 Sigma-Aldrich Recent Development
13.6 New England Biolabs
13.6.1 New England Biolabs Company Details
13.6.2 New England Biolabs Business Overview
13.6.3 New England Biolabs Epigenetic Introduction
13.6.4 New England Biolabs Revenue in Epigenetic Business (2019-2020))
13.6.5 New England Biolabs Recent Development
13.7 Thermo Fisher Scientific
13.7.1 Thermo Fisher Scientific Company Details
13.7.2 Thermo Fisher Scientific Business Overview
13.7.3 Thermo Fisher Scientific Epigenetic Introduction
13.7.4 Thermo Fisher Scientific Revenue in Epigenetic Business (2019-2020))
13.7.5 Thermo Fisher Scientific Recent Development
13.8 Diagenode
13.8.1 Diagenode Company Details
13.8.2 Diagenode Business Overview
13.8.3 Diagenode Epigenetic Introduction
13.8.4 Diagenode Revenue in Epigenetic Business (2019-2020))
13.8.5 Diagenode Recent Development
13.9 Active Motif
13.9.1 Active Motif Company Details
13.9.2 Active Motif Business Overview
13.9.3 Active Motif Epigenetic Introduction
13.9.4 Active Motif Revenue in Epigenetic Business (2019-2020))
13.9.5 Active Motif Recent Development
13.10 Roche Diagnostics
13.10.1 Roche Diagnostics Company Details
13.10.2 Roche Diagnostics Business Overview
13.10.3 Roche Diagnostics Epigenetic Introduction
13.10.4 Roche Diagnostics Revenue in Epigenetic Business (2019-2020))
13.10.5 Roche Diagnostics Recent Development
13.11 Eisai
10.11.1 Eisai Company Details
10.11.2 Eisai Business Overview
10.11.3 Eisai Epigenetic Introduction
10.11.4 Eisai Revenue in Epigenetic Business (2019-2020))
10.11.5 Eisai Recent Development
13.12 Novartis
10.12.1 Novartis Company Details
10.12.2 Novartis Business Overview
10.12.3 Novartis Epigenetic Introduction
10.12.4 Novartis Revenue in Epigenetic Business (2019-2020))
10.12.5 Novartis Recent Development
14 Market Dynamics
14.1 Drivers
14.2 Challenges
14.3 Porter’s Five Forces Analysis
14.4 Market Ecosystem and Value Chain Analysis
15 Key Findings in This Report
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Epigenetic Key Market Segments
Table 2. Key Players Covered: Ranking by Epigenetic Revenue
Table 3. Ranking of Global Top Epigenetic Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Epigenetic Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Reagents
Table 6. Key Players of Kits
Table 7. Key Players of Instruments
Table 8. Key Players of Enzymes
Table 9. Key Players of Services
Table 10. Global Epigenetic Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Epigenetic Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Epigenetic Market Size by Regions (US$ Million): 2020 VS 2026
Table 13. Global Epigenetic Market Share by Regions 2019-2026
Table 14. Market Top Trends
Table 15. Market Use Cases
Table 16. Global Epigenetic Revenue by Players (2019-2020) (Million US$)
Table 17. Global Epigenetic Market Share by Players (2019-2020)
Table 18. Key Players Headquarters and Area Served
Table 19. Key Players Epigenetic Product Solution and Service
Table 20. Date of Enter into Epigenetic Market
Table 21. Global Key Players Epigenetic Funding/Investment Analysis (Million USD)
Table 22. Global Key Players Epigenetic Valuation & Market Capitalization (Million USD)
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Epigenetic Market Size by Type (2019-2026) (Million US$)
Table 25. Global Epigenetic Market Size Share by Type (2019-2026)
Table 26. Global Epigenetic Market Size by Application (2019-2026) (Million US$)
Table 27. Global Epigenetic Market Size Share by Application (2019-2026)
Table 28. North America Key Players Epigenetic Revenue (2019-2020) (Million US$)
Table 29. North America Key Players Epigenetic Market Share (2019-2020)
Table 30. North America Epigenetic Market Size by Type (2019-2026) (Million US$)
Table 31. North America Epigenetic Market Share by Type (2019-2026)
Table 32. North America Epigenetic Market Size by Application (2019-2026) (Million US$)
Table 33. North America Epigenetic Market Share by Application (2019-2026)
Table 34. Europe Key Players Epigenetic Revenue (2019-2020) (Million US$)
Table 35. Europe Key Players Epigenetic Market Share (2019-2020)
Table 36. Europe Epigenetic Market Size by Type (2019-2026) (Million US$)
Table 37. Europe Epigenetic Market Share by Type (2019-2026)
Table 38. Europe Epigenetic Market Size by Application (2019-2026) (Million US$)
Table 39. Europe Epigenetic Market Share by Application (2019-2026)
Table 40. China Key Players Epigenetic Revenue (2019-2020) (Million US$)
Table 41. China Key Players Epigenetic Market Share (2019-2020)
Table 42. China Epigenetic Market Size by Type (2019-2026) (Million US$)
Table 43. China Epigenetic Market Share by Type (2019-2026)
Table 44. China Epigenetic Market Size by Application (2019-2026) (Million US$)
Table 45. China Epigenetic Market Share by Application (2019-2026)
Table 46. Japan Key Players Epigenetic Revenue (2019-2020) (Million US$)
Table 47. Japan Key Players Epigenetic Market Share (2019-2020)
Table 48. Japan Epigenetic Market Size by Type (2019-2026) (Million US$)
Table 49. Japan Epigenetic Market Share by Type (2019-2026)
Table 50. Japan Epigenetic Market Size by Application (2019-2026) (Million US$)
Table 51. Japan Epigenetic Market Share by Application (2019-2026)
Table 52. Southeast Asia Key Players Epigenetic Revenue (2019-2020) (Million US$)
Table 53. Southeast Asia Key Players Epigenetic Market Share (2019-2020)
Table 54. Southeast Asia Epigenetic Market Size by Type (2019-2026) (Million US$)
Table 55. Southeast Asia Epigenetic Market Share by Type (2019-2026)
Table 56. Southeast Asia Epigenetic Market Size by Application (2019-2026) (Million US$)
Table 57. Southeast Asia Epigenetic Market Share by Application (2019-2026)
Table 58. India Key Players Epigenetic Revenue (2019-2020) (Million US$)
Table 59. India Key Players Epigenetic Market Share (2019-2020)
Table 60. India Epigenetic Market Size by Type (2019-2026) (Million US$)
Table 61. India Epigenetic Market Share by Type (2019-2026)
Table 62. India Epigenetic Market Size by Application (2019-2026) (Million US$)
Table 63. India Epigenetic Market Share by Application (2019-2026)
Table 64. Central & South America Key Players Epigenetic Revenue (2019-2020) (Million US$)
Table 65. Central & South America Key Players Epigenetic Market Share (2019-2020)
Table 66. Central & South America Epigenetic Market Size by Type (2019-2026) (Million US$)
Table 67. Central & South America Epigenetic Market Share by Type (2019-2026)
Table 68. Central & South America Epigenetic Market Size by Application (2019-2026) (Million US$)
Table 69. Central & South America Epigenetic Market Share by Application (2019-2026)
Table 70. Illumina Company Details
Table 71. Illumina Business Overview
Table 72. Illumina Product
Table 73. Company Description and Business Overview
Table 74. Illumina Epigenetic Product
Table 75. Illumina Revenue in Epigenetic Business 2019 and 2020 (Million US$)
Table 76. Illumina Recent Development
Table 77. Qiagen Company Details
Table 78. Qiagen Business Overview
Table 79. Qiagen Product
Table 80. Company Description and Business Overview
Table 81. Qiagen Epigenetic Product
Table 82. Qiagen Revenue in Epigenetic Business 2019 and 2020 (Million US$)
Table 83. Qiagen Recent Development
Table 84. Abcam Company Details
Table 85. Abcam Business Overview
Table 86. Abcam Product
Table 87. Company Description and Business Overview
Table 88. Abcam Epigenetic Product
Table 89. Abcam Revenue in Epigenetic Business 2019 and 2020 (Million US$)
Table 90. Abcam Recent Development
Table 91. Merck & Co Company Details
Table 92. Merck & Co Business Overview
Table 93. Merck & Co Product
Table 94. Company Description and Business Overview
Table 95. Merck & Co Epigenetic Product
Table 96. Merck & Co Revenue in Epigenetic Business 2019 and 2020 (Million US$)
Table 97. Merck & Co Recent Development
Table 98. Sigma-Aldrich Company Details
Table 99. Sigma-Aldrich Business Overview
Table 100. Sigma-Aldrich Product
Table 101. Company Description and Business Overview
Table 102. Sigma-Aldrich Epigenetic Product
Table 103. Sigma-Aldrich Revenue in Epigenetic Business 2019 and 2020 (Million US$)
Table 104. Sigma-Aldrich Recent Development
Table 105. New England Biolabs Company Details
Table 106. New England Biolabs Business Overview
Table 107. New England Biolabs Product
Table 108. Company Description and Business Overview
Table 109. New England Biolabs Epigenetic Product
Table 110. New England Biolabs Revenue in Epigenetic Business 2019 and 2020 (Million US$)
Table 111. New England Biolabs Recent Development
Table 112. Thermo Fisher Scientific Company Details
Table 113. Thermo Fisher Scientific Business Overview
Table 114. Thermo Fisher Scientific Product
Table 115. Company Description and Business Overview
Table 116. Thermo Fisher Scientific Epigenetic Product
Table 117. Thermo Fisher Scientific Revenue in Epigenetic Business 2019 and 2020 (Million US$)
Table 118. Thermo Fisher Scientific Recent Development
Table 119. Diagenode Business Overview
Table 120. Diagenode Product
Table 121. Diagenode Company Details
Table 122. Company Description and Business Overview
Table 123. Diagenode Epigenetic Product
Table 124. Diagenode Revenue in Epigenetic Business 2019 and 2020 (Million US$)
Table 125. Diagenode Recent Development
Table 126. Active Motif Company Details
Table 127. Active Motif Business Overview
Table 128. Active Motif Product
Table 129. Company Description and Business Overview
Table 130. Active Motif Epigenetic Product
Table 131. Active Motif Revenue in Epigenetic Business 2019 and 2020 (Million US$)
Table 132. Active Motif Recent Development
Table 133. Roche Diagnostics Company Details
Table 134. Roche Diagnostics Business Overview
Table 135. Roche Diagnostics Product
Table 136. Company Description and Business Overview
Table 137. Roche Diagnostics Epigenetic Product
Table 138. Roche Diagnostics Revenue in Epigenetic Business 2019 and 2020 (Million US$)
Table 139. Roche Diagnostics Recent Development
Table 140. Eisai Company Details
Table 141. Eisai Business Overview
Table 142. Eisai Product
Table 143. Company Description and Business Overview
Table 144. Eisai Epigenetic Product
Table 145. Eisai Revenue in Epigenetic Business 2019 and 2020 (Million US$)
Table 146. Eisai Recent Development
Table 147. Novartis Company Details
Table 148. Novartis Business Overview
Table 149. Novartis Product
Table 150. Company Description and Business Overview
Table 151. Novartis Epigenetic Product
Table 152. Novartis Revenue in Epigenetic Business 2019 and 2020 (Million US$)
Table 153. Novartis Recent Development
Table 154. Company Description and Business Overview
Table 155. Company Description and Business Overview
Table 156. Company Description and Business Overview
Table 157. Company Description and Business Overview
Table 158. Company Description and Business Overview
Table 159. Company Description and Business Overview
Table 160. Company Description and Business Overview
Table 161. Company Description and Business Overview
Table 162. Company Description and Business Overview
Table 163. Company Description and Business Overview
Table 164. Company Description and Business Overview
Table 165. Company Description and Business Overview
Table 166. Company Description and Business Overview
Table 167. Company Description and Business Overview
Table 168. Company Description and Business Overview
Table 169. Company Description and Business Overview
Table 170. Company Description and Business Overview
Table 171. Company Description and Business Overview
Table 172. Company Description and Business Overview
Table 173. Company Description and Business Overview
Table 174. Company Description and Business Overview
Table 175. Company Description and Business Overview
Table 176. Company Description and Business Overview
Table 177. Company Description and Business Overview
Table 178. Company Description and Business Overview
Table 179. Company Description and Business Overview
Table 180. Company Description and Business Overview
Table 181. Company Description and Business Overview
Table 182. Key Drivers: Impact Analysis (2021-2026)
Table 183. Key Opportunities
Table 184. Key Challenges
Table 185. Research Programs/Design for This Report
Table 186. Key Data Information from Secondary Sources
Table 187. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Epigenetic Market Share by Type: 2020 VS 2026
Figure 2. Reagents Features
Figure 3. Kits Features
Figure 4. Instruments Features
Figure 5. Enzymes Features
Figure 6. Services Features
Figure 7. Global Epigenetic Market Share by Application: 2020 VS 2026
Figure 8. Academic Research Institutes Case Studies
Figure 9. Biotechnology Companies Case Studies
Figure 10. Biopharmaceutical Companies Case Studies
Figure 11. Diagnostic Companies Case Studies
Figure 12. Epigenetic Report Years Considered
Figure 13. Global Epigenetic and Growth Rate (2019-2026) (Million US$)
Figure 14. Global Epigenetic Market Share by Regions (2019-2026)
Figure 15. Global Epigenetic Market Share by Players in 2019
Figure 16. Global Epigenetic Market Size Market Share by Type (2019-2026)
Figure 17. Global Epigenetic Market Size Market Share by Application (2019-2026)
Figure 18. North America Epigenetic Market Size YoY Growth (2019-2026) (Million US$)
Figure 19. Europe Epigenetic Market Size YoY Growth (2019-2026) (Million US$)
Figure 20. China Epigenetic Market Size YoY Growth (2019-2026) (Million US$)
Figure 21. Japan Epigenetic Market Size YoY Growth (2019-2026) (Million US$)
Figure 22. Southeast Asia Epigenetic Market Size YoY Growth (2019-2026) (Million US$)
Figure 23. India Epigenetic Market Size YoY Growth (2019-2026) (Million US$)
Figure 24. Central & South America Epigenetic Market Size YoY Growth (2019-2026) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
分子生物学酵素・キット・試薬の世界市場（～2026年） There is a rise in the prevalence of genetic disorders since the recent past, which in turn has driven adoption of molecular diagnostics. Key processes of molecular diagnostics such as epigenetics and polymerase chain reaction (PCR) require molecular biology enzymes, kits & reagents. With mounting i…- ゲノミクス・プロテオミクス試薬・研究キット・分析機器の世界市場（～2026年） The market is segmented into two major areas, namely, the genomics and proteomics reagent kits market and the genomics and proteomics analytical tools market. The reagent and research kits segment deals with the products used in sample preparation, purification and isolation, electrophoresis, lab-on…
- バイオテクノロジー試薬の世界市場（～2026年） Biotechnology reagents - used in the field of diagnosis, genetics, research, molecular biology, education, immunology, and bioscience – are compounds or substances used to synthesize, examine, or detect the presence of another substance to enable test reading. Biotechnology reagents comprise technol…
- ライフサイエンス機器・試薬の世界市場（～2026年） Market Analysis and Insights: Global Life Science Instruments & Reagents Market The global Life Science Instruments & Reagents market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Life Science Instruments & Reagents Scope a…
- DNAライブラリープレパレーションキットの世界市場（～2026年） DNA library preparation kit is collectively set of improved reagents which are used to convert the small amount of DNA into indexed libraries. DNA library kits are used in next-generation sequencing for conversion of small amount of DNA. DNA library preparation kits are developed on the basis of Tn5…